Medical Marijuana Inc (OTCMKTS:MJNA) has been on the rise after a brief dip below the $0.10 mark. MJNA saw an explosive move up with the rest of the sector leading up to the elections hitting $0.25 a share but failed to take out $0.268 previous highs of November. MJNA remains an Investors favorite and a staple among the top most traded stocks on the entire exchange especially when pot stocks heat up.
MJNA is one of the original pot stocks on the OTC and has always been a great place to be when the sector takes off with its history of parabolic moves; the Marijuana industry has quickly turned into a multi-billion dollar massive growth market that is sweeping across the Country with many new states legalizing the drug including California, Nevada, Maine, and Massachusetts on November 8.
Medical Marijuana Inc (OTCMKTS:MJNA) mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. They strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value.
MJNA most profitable division is HempMeds, an exclusive master distributor for MJNA that provides cannabidiol (CBD) products made from industrial hemp that are already available in all 50 states and more than 40 countries. The unit boasts fast growing revenues and reported $2,876,438 in sales in Q3.
MJNA says their HempMeds™ sales operation has been greatly streamlined and they have cut back on inefficient expenses. The world is waking up to the vast untapped potential of cannabinoid-rich hemp oil and our flagship product, Real Scientific Hemp Oil™ (RSHO™), continues to show increasing demand. Combining our reduced manufacturing costs with improving demand from lower retail prices – we expect to see improving gross margins as the year progresses. Over the course of the last year we have been able to decrease our retail sales price by over 30% while still increasing margins and overall volume.”
Several Months ago Project CBD, a California educational nonprofit that focuses on cannabis science and therapeutics published an article called HEMP OIL HUSTLERS; Medical Marijuana Inc., HempMeds & Kannaway that has raised a stir especially with MJNA management who filed a $100 million lawsuit. As per the recent shareholder letter ”To date, two parties have settled in our litigation.”
To Find out the inside Scoop on MJNA Subscribe to Microcapdaily.com Right Now by entering your Email in the box below
In September MJNA announced it has signed a U.S. manufacturer for sourcing of its Gold Label cannabidiol (CBD) hemp oil brand Real Scientific Hemp Oil™ (RSHO™). The sourcing agreement is for a minimum of $2,500,000 USD for a 12-month period. The first two months of the contract have already been sold, shipped and processed.
On July 20 MJNA annouinced it and its subsidiary HempMeds® Brasil garnered extensive media coverage across Brazil about the Company’s growth and the booming cannabis market across U.S. and Latin America.
A July 16, 2017 article from Rio de Janeiro-based Brazilian newspaper O Globo “Negócios que do a maior onda”, or “In the cannabis market, these businesses will get you high”, which was picked up by several other major news outlets across the Country, discussed the explosive growth projected for the cannabis market in the U.S. and Latin America and recent advances in legislation. The article also featured a global AFP photo of Medical Marijuana, Inc.’s products taken at the 4 [th] Annual Cannabis World Congress and Business Expo in New York City in June 2017.
“It’s encouraging to see the widespread global media coverage of the medical marijuana and CBD markets; we are always pleased to be at the forefront of discussion of one of the fastest growing industries in the world,” said CEO of Medical Marijuana, Inc. Dr. Stuart Titus. “A goal of our company has been to provide an alternative health-and-wellness approach to those who may fail conventional medical treatment.”
We have a Monster Pick Coming. Subscribe Right Now!
Currently trading at a $301 million market valuation MJNA has a long history of losses that has resulted in a massive debt problem that has caused and will continue to cause significant dilution. But MJNA is one pot stock to watch when the sector heats up; they are masters at selling the sizzle on the pot sector as well as getting themselves featured by mainstream media, in the past this has resulted in spectacular short term moves. We will be updating on MJNA when more details emerge so make sure you are subscribed to Microcapdaily so you know what’s going on with MJNA.
Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!
Disclosure: we hold no position in MJNA either long or short and we have not been compensated for this article.